Fresenius successfully completes divestment of Vamed’s rehabilitation business

The healthcare group Fresenius has achieved a further milestone in the implementation of #FutureFresenius with the successful completion of the divestment of Vamed’s rehabilitation business to the international private equity firm PAI Partners. Fresenius retains a minority stake of 30 percent in the business. The transaction, which was announced in May 2024, has received all necessary regulatory approvals and the closing conditions have been met.

The rehabilitation business which also includes specialized healthcare services in the areas of prevention, acute care and nursing, was Vamed's largest business unit. With approximately 13,000 employees, it provides inpatient and outpatient rehabilitation services to approximately 100,000 patients every year in various European countries.